The synthesis of novel glucagon-like peptide-1 receptor agonists presents a unique set of circumstances for pharmaceutical developers. Biopharmaceutical companies often require specialized manufacturing solutions to fulfill the specific requirements of these complex molecules. Our group provides customizable GLP-1 receptor agonist manufacturing ser